Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review

Código QR

Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review

Jonathan Aguirre Valadez,1 Ignacio García Juárez,1 Rodolfo Rincón Pedrero,2 Aldo Torre11Department of Gastroenterology, 2Department of Nephrology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico Abstract: Infecti...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Aguirre Valadez J, García Juárez I, Rincón Pedrero R, Torre A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/a29c211840f34641bbefcec2713fcb46
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Chronic hepatitis C: future treatment
por: Wendt A, et al.
Publicado: (2014)

PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients
por: Stefan Willmann, et al.
Publicado: (2021)

Multiscale model of hepatitis C virus dynamics in plasma and liver following combination therapy
por: Xavier Woot de Trixhe, et al.
Publicado: (2021)

High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure
por: Yabuno K, et al.
Publicado: (2013)

Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review
por: Pacifici GM
Publicado: (2014)

Juzentaihoto improves adenine-induced chronic renal failure in BALB/c mice via suppression of renal fibrosis and inflammation
por: Satoyasu Ito, et al.
Publicado: (2022)

Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent
por: Gillian W Reierson, et al.
Publicado: (2009)

The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
por: Davies M, et al.
Publicado: (2016)

Analysis of factors affecting rehospitalization of patients with chronic kidney disease after educational hospitalization
por: Kose E, et al.
Publicado: (2014)

The association between NAFLD and risk of chronic kidney disease: a cross-sectional study
por: Ying Cao, et al.
Publicado: (2021)

Hemodialysis does not alter in vitro hepatic CYP3A4 and CYP2D6 metabolic activity in uremic serum
por: Decker BS, et al.
Publicado: (2013)

Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy
por: Michael A. Tortorici, et al.
Publicado: (2021)

Population pharmacokinetic and exposure–response analyses of intravenous and subcutaneous rituximab in patients with chronic lymphocytic leukemia
por: Ekaterina Gibiansky, et al.
Publicado: (2021)

Impact of the chronic disease self-management program (CDSMP) on self-perceived frailty condition: the EU-EFFICHRONIC project
por: Sabrina Zora, et al.
Publicado: (2021)

A Debate on Vitamin C: Supplementation on the Hotline for Critically Ill Patients with COVID-19
por: Ata Mahmoodpoor, et al.
Publicado: (2020)

“Highly Exposed Chinese Herbal Medicine” Combined With Apatinib as Maintenance Treatment Following First-Line or Second-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Single-Arm, Prospective Study
por: Mingqi Wang, et al.
Publicado: (2021)

The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein&ndash;Barr virus disease
por: Heather&nbsp;E Vezina, et al.
Publicado: (2009)

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response
por: Li L, et al.
Publicado: (2012)

Virtual clinical trial simulations for a novel KRASG12C inhibitor (ASP2453) in non‐small cell lung cancer
por: Hiroyuki Sayama, et al.
Publicado: (2021)

Modern approaches to pharmacotherapy of tuberculosis infection in children
por: Vasiliy E. Novikov, et al.
Publicado: (2021)

Implications of compromised zinc status on bone loss associated with chronic inflammation in C57BL/6 mice
por: Chongwatpol P, et al.
Publicado: (2015)

Investigation of pulmonary infection pathogens in neurological intensive care unit
por: Fengying Quan, et al.
Publicado: (2011)

Establishment of a rotavirus-infected zebrafish model and its application in drug screening
por: Lijun Song, et al.
Publicado: (2022)

Distribution and Resistance of Pathogens in Liver Transplant Recipients with Acinetobacter baumannii Infection [Expression of Concern] [Erratum]
por: Gao F, et al.
Publicado: (2020)

Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens
por: Matsumoto T
Publicado: (2014)

Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease
por: Ishii T, et al.
Publicado: (2021)

Respiratory metapneumoviral infection without co-infection in association with acute and chronic lung allograft dysfunction
por: Dosanjh A
Publicado: (2015)

IL-1α correlates with severity of hepatitis C virus-related liver diseases
por: Tawfik AK, et al.
Publicado: (2018)

Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling
por: Heajin Jun, et al.
Publicado: (2020)

Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study
por: François Riglet, et al.
Publicado: (2020)

Pharmacological properties of selenium and its preparations: from antioxidant to neuroprotector
por: Igor F. Belenichev, et al.
Publicado: (2021)

Is antibiotics overuse justified when immediate intervention is not possible? A rapid evidence review
por: Nour Ibrahim, et al.
Publicado: (2021)

Sodium Bicarbonate Nebulized Therapy in Patients with Confirmed COVID-19
por: Jalil Rashedi, et al.
Publicado: (2020)

Book of Abstracts 38th Technology Days 9th and 10th September 2021
por: Molitorisová M.
Publicado: (2021)

Optimal management of Barrett&#39;s esophagus: pharmacologic, endoscopic, and surgical interventions
por: Konda VJA, et al.
Publicado: (2011)

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model [Corrigendum]
por: Lozano R, et al.
Publicado: (2013)

AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects
por: Michael R Graham, et al.
Publicado: (2008)

Impact of denosumab on bone mass in cancer patients
por: Brown-Glaberman U, et al.
Publicado: (2013)

The Parkinson's disease death rate: carbidopa and vitamin B6
por: Hinz M, et al.
Publicado: (2014)

Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response
por: Kreutz RP, et al.
Publicado: (2013)